Beta Carotene
FDA-approved product (capsule, oral), marketed as Solatene.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Beta Carotene. Its therapeutic class is shown instead.
- WHO therapeutic group
- Vitamin a, plain; Protectives against uv-radiation for systemic use
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Beta Carotene, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA18.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli22.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae10.2% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis35.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Beta Carotene with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Effects of Vitamin A and Carotenoids on Iron Absorption
NCT01493297 · start 2011-09
Registered record
- Registry ID
- NCT01493297
- Conditions
- Iron Absorption
- Interventions
- Labeled iron solutions
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-09
- Completion
- 2012-07
- Enrolment
- 25
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron AbsorptionInterventionLabeled iron solutionsPhaseNot applicableRegistry statusCompletedVitamin A Absorption From Cassava in Women
NCT01381276 · start 2011-06
Registered record
- Registry ID
- NCT01381276
- Conditions
- Vitamin A Deficiency
- Interventions
- Beta-Carotene bio-fortified cassava porridge without oil; Beta-Carotene bio-fortified cassava porridge with oil; White cassava porridge with retinyl palmitate reference dose
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2011-06
- Completion
- 2011-10
- Enrolment
- 10
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin A DeficiencyInterventionBeta-Carotene bio-fortified cassava porridge without oil; Beta-Carotene bio-fortified cassava porridge with oil; White cassava porridge with retinyl palmitate reference dosePhasePhase 2Registry statusCompletedLow Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals
NCT01477112 · start 2010-01
Registered record
- Registry ID
- NCT01477112
- Conditions
- Diabetes Mellitus; Oxidative Stress; Iron Metabolism Disorders
- Interventions
- Betacarotene; Controls. No treatment
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-01
- Completion
- 2010-12
- Enrolment
- 117
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDiabetes Mellitus; Oxidative Stress; Iron Metabolism DisordersInterventionBetacarotene; Controls. No treatmentPhaseNot applicableRegistry statusCompletedCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
NCT00866918 · start 2009-03-09
Registered record
- Registry ID
- NCT00866918
- Conditions
- Childhood Acute Promyelocytic Leukemia With PML-RARA; Myeloid Neoplasm
- Interventions
- Arsenic Trioxide; Cytarabine; Diagnostic Laboratory Biomarker Analysis; Idarubicin; Mercaptopurine; Methotrexate; Mitoxantrone Hydrochloride; Tretinoin
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2009-03-09
- Completion
- 2022-09-30
- Enrolment
- 106
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChildhood Acute Promyelocytic Leukemia With PML-RARA; Myeloid NeoplasmInterventionArsenic Trioxide; Cytarabine; Diagnostic Laboratory Biomarker Analysis; Idarubicin +4 morePhasePhase 3Registry statusCompletedMicronutrients to Prevent Noise-induced Hearing Loss
NCT00808470 · start 2008-10
Registered record
- Registry ID
- NCT00808470
- Conditions
- Noise-Induced Hearing Loss
- Interventions
- beta-carotene, vitamins C and E, magnesium; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2008-10
- Completion
- 2013-12
- Enrolment
- 72
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNoise-Induced Hearing LossInterventionbeta-carotene, vitamins C and E, magnesium; PlaceboPhasePhase 2Registry statusCompletedCombined Vitamins and Minerals Decrease Incidence of Upper Respiratory Tract Infections in Older Persons
NCT01484756 · start 2008-08
Registered record
- Registry ID
- NCT01484756
- Conditions
- Upper Respiratory Tract Infection
- Interventions
- daily multi micronutrient supplement; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2008-08
- Completion
- 2009-03
- Enrolment
- 270
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionUpper Respiratory Tract InfectionInterventiondaily multi micronutrient supplement; PlaceboPhasePhase 3Registry statusCompletedVitamin A Equivalence of Plant Carotenoids in Children
NCT00680212 · start 2008-07
Registered record
- Registry ID
- NCT00680212
- Conditions
- Vitamin A Deficiency
- Interventions
- dietary carotenoids; spinach, rice, and synthetic beta-carotene
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2008-07
- Completion
- 2009-01
- Enrolment
- 72
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin A DeficiencyInterventiondietary carotenoids; spinach, rice, and synthetic beta-carotenePhasePhase 2Registry statusCompletedVitamin/Mineral Supplement for Children and Adults With Autism
NCT01225198 · start 2008-05
Registered record
- Registry ID
- NCT01225198
- Conditions
- Autism
- Interventions
- Multi-Vitamin/Mineral Supplement; Liquid Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2008-05
- Completion
- 2009-02
- Enrolment
- 143
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAutismInterventionMulti-Vitamin/Mineral Supplement; Liquid PlaceboPhasePhase 2Registry statusCompletedGlutathione Metabolism in Adolescents With Type 1 Diabetes - Study B
NCT00858273 · start 2008-03
Registered record
- Registry ID
- NCT00858273
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Antioxidant supplement; Diabetes treatment; Regular Insulin
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2008-03
- Completion
- 2011-08
- Enrolment
- 41
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDiabetes Mellitus, Type 1InterventionAntioxidant supplement; Diabetes treatment; Regular InsulinPhaseNot applicableRegistry statusCompletedHuman Lycopene and Beta-cryptoxanthin Absorption From Citrus Fruit
NCT02348164 · start 2007-12
Registered record
- Registry ID
- NCT02348164
- Conditions
- Bioavailability of Carotenoids
- Interventions
- Pink grapefruit first followed by tangerines two weeks later; Tangerines first followed by pink grapefruit two weeks later
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-12
- Completion
- 2009-02
- Enrolment
- 23
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBioavailability of CarotenoidsInterventionPink grapefruit first followed by tangerines two weeks later; Tangerines first followed by pink grapefruit two weeks laterPhaseNot applicableRegistry statusCompletedA Randomized Controlled Trial Testing The Effect Of A Multi-Nutrient Fortified Juice
NCT01909063 · start 2005-01
Registered record
- Registry ID
- NCT01909063
- Conditions
- Vitamin D Deficiency; Hypovitaminosis A; Vitamin E Deficiency
- Interventions
- Vitamin D; Vitamin D, Vitamin E, and Vitamin A; Control, 700 mg Calcium
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2005-01
- Completion
- 2008-01
- Enrolment
- 180
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin D Deficiency; Hypovitaminosis A; Vitamin E DeficiencyInterventionVitamin D; Vitamin D, Vitamin E, and Vitamin A; Control, 700 mg CalciumPhaseNot applicableRegistry statusCompletedVitamins, Breastmilk HIV Shedding, and Child Health
NCT00197756 · start 2004-09
Registered record
- Registry ID
- NCT00197756
- Conditions
- Maternal and Child Health Outcomes
- Interventions
- Vitamin A alone; Multivitamins excluding vitamin A; multivitamins including vitamin A; Placebo
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2004-09
- Completion
- 2007-08
- Enrolment
- 771
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMaternal and Child Health OutcomesInterventionVitamin A alone; Multivitamins excluding vitamin A; multivitamins including vitamin A; PlaceboPhaseNot recordedRegistry statusCompletedThe CARO Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects
NCT00128752 · start 2003-03
Registered record
- Registry ID
- NCT00128752
- Conditions
- Healthy
- Interventions
- absorption and conversion of beta-carotene in human gastrointestinal (GI) tract
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2003-03
- Completion
- 2003-10
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthyInterventionabsorption and conversion of beta-carotene in human gastrointestinal (GI) tractPhaseNot applicableRegistry statusCompletedBeta Carotene From Natural Source for Patients With Non-Active Crohn's Disease
NCT00275418 · start 2002-07
Registered record
- Registry ID
- NCT00275418
- Conditions
- Crohn's Disease
- Interventions
- beta carotene from Dunaliella algae
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2002-07
- Completion
- Not recorded
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCrohn's DiseaseInterventionbeta carotene from Dunaliella algaePhasePhase 3Registry statusUnknownAlpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
NCT00342992 · start 1995-03-03
Registered record
- Registry ID
- NCT00342992
- Conditions
- Stroke; Diabetes Mellitus; Heart Disease; Cancer
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 1995-03-03
- Completion
- 2020-09-04
- Enrolment
- 29,133
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStroke; Diabetes Mellitus; Heart Disease; CancerInterventionNot recordedPhaseNot recordedRegistry statusCompleted